Global Bioenergies (ALGBE) | Financial Analysis & Statements
Global Bioenergies S.A. | Small-cap | Utilities
Global Bioenergies S.A. | Small-cap | Utilities
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
360.7K
Gross Profit
-213.7K
-59.26%
Operating Income
-6.1M
-1,689.49%
Net Income
-5.9M
-1,625.06%
Balance Sheet Metrics
Total Assets
9.7M
Total Liabilities
8.0M
Shareholders Equity
1.7M
Debt to Equity
4.70
Cash Flow Metrics
Operating Cash Flow
-8.9M
Free Cash Flow
-8.0M
Revenue & Profitability Trend
Global Bioenergies Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 360.7K | 3.2M | 697.5K | 100.9K | 63.8K |
| Cost of Goods Sold | 574.4K | 3.3M | -1.1M | 680.7K | -282.6K |
| Gross Profit | -213.7K | -83.6K | 1.8M | -579.8K | 346.5K |
| Operating Expenses | 3.4M | 5.7M | 9.1M | 9.6M | 8.6M |
| Operating Income | -6.1M | -6.8M | -11.6M | -12.2M | -13.0M |
| Pre-tax Income | -7.1M | -9.8M | -13.4M | -13.5M | -13.2M |
| Income Tax | -1.3M | -1.2M | -1.4M | -1.7M | -2.3M |
| Net Income | -5.9M | -8.7M | -12.0M | -11.8M | -10.9M |
| EPS (Diluted) | - | -€0.48 | -€0.80 | -€0.78 | -€1.08 |
Income Statement Trend
Global Bioenergies Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 8.7M | 15.0M | 15.5M | 26.9M | 21.9M |
| Non-Current Assets | 904.4K | 3.2M | 6.1M | 4.9M | 3.9M |
| Total Assets | 9.7M | 18.3M | 21.6M | 31.8M | 25.8M |
| Liabilities | |||||
| Current Liabilities | 6.0M | 3.0M | 7.4M | 7.9M | 16.2M |
| Non-Current Liabilities | 2.0M | 4.9M | 6.5M | 5.2M | 334.3K |
| Total Liabilities | 8.0M | 7.8M | 13.9M | 13.1M | 16.6M |
| Equity | |||||
| Total Shareholders Equity | 1.7M | 10.4M | 7.6M | 18.7M | 9.2M |
Balance Sheet Composition
Global Bioenergies Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -5.9M | -8.7M | -12.0M | -11.8M | -11.1M |
| Operating Cash Flow | -8.9M | -8.7M | -12.0M | -11.8M | -11.1M |
| Investing Activities | |||||
| Capital Expenditures | -466.0K | -325.4K | -2.0M | 3.5K | - |
| Investing Cash Flow | -466.0K | 887.5K | -1.9M | 355.2K | - |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 990.1K | 3.4M | -125.4K | 21.2M | 9.6M |
| Free Cash Flow | -8.0M | -8.2M | -12.1M | -14.7M | -11.3M |
Cash Flow Trend
Global Bioenergies Key Financial Ratios
Valuation Ratios
Price to Book
0.90
Price to Sales
4.23
Profitability Ratios
Profit Margin
-59.26%
Operating Margin
-17,560.98%
Return on Equity
-96.88%
Return on Assets
-30.21%
Financial Health
Current Ratio
1.43
Debt to Equity
334.06
Beta
1.44
Per Share Data
EPS (TTM)
-€0.32
Book Value per Share
€0.09
Revenue per Share
€0.02
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| algbe | 1.5M | - | 0.90 | -96.88% | -59.26% | 334.06 |
| Methanor S.C.A | 7.5M | 17.67 | 0.53 | -5.39% | 100.00% | 0.00 |
| Weyerhaeuser Company | 161.4K | -0.01 | - | 554.96% | 1.71% | - |
| Engie S.A | 48.1B | 11.96 | 1.57 | 12.89% | 5.56% | 126.49 |
| Teleperformance SE | 4.7B | 8.74 | 0.99 | 11.91% | 5.09% | 108.71 |
| Orange S.A | 33.9B | 16.98 | 1.07 | 7.67% | 5.84% | 121.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.